Advisors Asset Management, Inc. Crispr Therapeutics Ag Transaction History

Advisors Asset Management, Inc.

$5.23 Billion
Q4 2024

A detailed history of Advisors Asset Management, Inc. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 7,724 shares of CRSP stock, worth $335,916. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,724

Previous 9,669 20.12%

Holding current value

$335,916

Previous $454,000 33.04%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$38.65 - $55.15 $75,174 - $107,266	-1,945 Reduced 20.12%	7,724 $304,000
Q3 2024 Nov 08, 2024	BUY	$44.62 - $62.75 $15,260 - $21,460	342 Added 3.67%	9,669 $454,000
Q2 2024 Aug 14, 2024	SELL	$51.17 - $68.18 $6,907 - $9,204	-135 Reduced 1.43%	9,327 $503,000
Q1 2024 May 14, 2024	BUY	$60.67 - $89.12 $170,725 - $250,783	2,814 Added 42.33%	9,462 $644,000
Q4 2023 Feb 14, 2024	BUY	$38.62 - $72.18 $36,186 - $67,632	937 Added 16.41%	6,648 $416,000
Q2 2023 Aug 14, 2023	SELL	$43.47 - $67.77 $264,906 - $412,990	-6,094 Reduced 51.62%	5,711 $320,000
Q1 2023 May 12, 2023	SELL	$41.0 - $56.12 $4,100 - $5,612	-100 Reduced 0.84%	11,805 $533,000
Q4 2022 Feb 13, 2023	SELL	$39.19 - $65.67 $411,847 - $690,126	-10,509 Reduced 46.89%	11,905 $483,000
Q3 2022 Nov 08, 2022	SELL	$61.1 - $83.78 $90,489 - $124,078	-1,481 Reduced 6.2%	22,414 $1.47 Million
Q2 2022 Aug 08, 2022	SELL	$43.23 - $73.83 $163,193 - $278,708	-3,775 Reduced 13.64%	23,895 $1.45 Million
Q1 2022 May 17, 2022	SELL	$53.19 - $79.24 $495,039 - $737,486	-9,307 Reduced 25.17%	27,670 $1.74 Million
Q4 2021 Feb 15, 2022	SELL	$70.09 - $111.29 $57,263 - $90,923	-817 Reduced 2.16%	36,977 $2.8 Million
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $407,960 - $579,881	3,702 Added 10.86%	37,794 $4.23 Million
Q2 2021 Jul 30, 2021	BUY	$100.84 - $161.89 $532,838 - $855,426	5,284 Added 18.34%	34,092 $5.52 Million
Q1 2021 May 07, 2021	BUY	$110.72 - $210.04 $1.33 Million - $2.53 Million	12,024 Added 71.64%	28,808 $3.51 Million
Q4 2020 Feb 12, 2021	BUY	$79.67 - $173.23 $1.06 Million - $2.3 Million	13,251 Added 375.06%	16,784 $2.57 Million
Q3 2020 Nov 16, 2020	BUY	$78.5 - $100.64 $128,426 - $164,647	1,636 Added 86.24%	3,533 $296,000
Q2 2020 Aug 12, 2020	BUY	$38.5 - $76.05 $73,034 - $144,266	1,897 New	1,897 $139,000

Others Institutions Holding CRSP

# of Institutions

488

Shares Held

60.3M

Call Options Held

1.26M

Put Options Held

1.81M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.39B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Crispr Therapeutics Ag Transaction History